Ignite Creation Date:
2024-05-11 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06410040
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-10
First Post:
2024-05-05
Brief Title:
A Retrospective Study of the Efficacy and Safety of Lolatinib in ALK NSCLC Patients With Brain or Meningeal Metastasis
Sponsor:
Sichuan Cancer Hospital and Research Institute
Organization:
Sichuan Cancer Hospital and Research Institute
Organization Data
Organization:
Sichuan Cancer Hospital and Research Institute
Class:
OTHER
Study ID:
EK2023003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sichuan Cancer Hospital and Research Institute
Lead Sponsor Class:
OTHER
Responsible Party:
Juan LI MD
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Sichuan Cancer Hospital and Research Institute
Old Name:
None
Old Organization:
None